The Making of a Healthcare Giant: Manipal’s Journey Across India

Date:

Share post:

In 1991, Dr Ramdas Pai- son of T.M.A Pai, founder of Manipal town set out to do something. India desperately needed: build serious multi speciality healthcare infrastructure for people who had none. Manipal hospitals was born from that ambition and it would go on to become one of the country’s most influential healthcare networks.

The early days weren’t easy. Specialised medical infrastructure was scarce and steep import taxes made building world class facilities an uphill battle. But Manipal had one powerful advantage. Its reputation as an educational institution. That credibility helped reverse the brain drain, drawing top physicians and clinicians back from across the globe to practice on Indian soil.

Through the 1990s, Manipal expanded steadily across South India setting up secondary and tertiary care Centre. By the early 2000s, growth accelerated, capacity crossed 2000 beds, and the group made a pivotal strategic shift from organic growth to acquisition led expansion. Backed by private equity players like Kotak and TPG, Manipal made its move into north India transforming from a regional player into National force.

Today the results speak for themselves. Manipal‘s acquisition strategy has significantly widened its bed capacity and geographic footprint . In 2024, its research wing secures multiple patents for AI driven diagnostic tools, sharpening its clinical edge. The group has also been honoured with several golden peacock national awards, recognising its consistency in healthcare delivery.

Yet with rapid growth comes a real challenge, maintaining quality across every new facility, protecting both reputation and regulatory standing.

Manipal’s journey proves that healthcare expansion isn’t just about scale. It’s about scaling without ever compromising care.

Written by: Srabanti Bhattacharjee

Graphics by: Sowmyodeep Roy

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

MSD Inaugurates New Technology Centre in Hyderabad to Drive Global Healthcare Innovation and Digital Capabilities

MSD (Merck & Co., Inc.), one of the world's leading global life sciences companies, has officially inaugurated its...

Bharat Technology Announces BT-PHARMACON 2K26 with Focus on Indigenous Pharma Innovation

Bharat Technology is set to organise BT-PHARMACON 2K26, an ANRF-sponsored national conference on September 26–27, 2026, at the Eastern Zonal...

ChrysCapital to Acquire 20-25% Stake in Linux Laboratories for ₹600 Crore

Private equity firm ChrysCapital is all set to acquire a strategic stake in Linux Laboratories, a Chennai-based specialty pharmaceutical company focused on central nervous...

India Spotlights Massive Health Workforce Expansion at WHO RC79; SEARO Adopts Historic Dili Declaration

The Ministerial Roundtable addressing on"Human Resources for Health: Equity in Specialized Care" at the 79th Session of the WHO Regional...